US 11534493
Pharmaceutical compositions of roflumilast in aqueous blends of water-miscible, pharmaceutically acceptable solvents
granted A61KA61K2300/00A61K31/44
Quick answer
US patent 11534493 (Pharmaceutical compositions of roflumilast in aqueous blends of water-miscible, pharmaceutically acceptable solvents) held by ARCUTIS BIOTHERAPEUTICS, INC. expires Mon Dec 22 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- ARCUTIS BIOTHERAPEUTICS, INC.
- Grant date
- Tue Dec 27 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 22 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 2
- CPC classes
- A61K, A61K2300/00, A61K31/44, A61K47/10, A61K9/0014